Search Results 1831-1840 of 16343 for Chiari malformation
Subjects with newly detected bradycardia -tachycardia syndrome and AF who have been recently (less than 3 weeks) started on warfarin, have a therapeutic ...
... syndrome, Bradycardia, Supraventricular tachycardia, Atrial flutter, Ventricular tachycardia, Ventricular fibrillation, Syncope, Heart palpitations, Atrial ...
Amylase ≤ 1 x ULN (Abnormality not of pancreatic origin is allowed); ... Known history of testing positive for human immunodeficiency virus (HIV), or acquired ...
Known prolongation of the QT interval (>480 msec), a history of torsades de pointes, congenital long QT syndrome, bradyarrhythmias or uncompensated heart ...
This is a 3-day study comparing pyridostigmine versus placebo in the treatment of postural tachycardia syndrome (POTS). The researchers expect pyridostigmine to ...
Degenerative connective tissue disease, e.g. Marfan's or Ehler-Danlos Syndrome; Participation in another drug or medical device study within 1 year of study ...
No abnormality that adversely impacts standard function of the knee. For the injured cohort, an acute ACL injury confirmed by MRI is required. For the ...
Clinically significant liver function test abnormalities. Has known human immunodeficiency virus (HIV), hepatitis C virus (HCV) or hepatitis B virus (HBV) ...
Known degenerative connective tissue disease, e.g., Marfan or Ehler-Danlos Syndrome; Planned concomitant surgical procedure or major surgery within 30 days ...
Congenital long QT syndrome;; QTcF ≥ 480 msec on screening ECG;; Unstable angina pectoris ≤ 3 months prior to starting study drug;; Acute myocardial ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.